Literature DB >> 29871561

Entry remnants in flow-diverted aneurysms: Does branch geometry influence aneurysm closure?

M Akli Zetchi1, Adam A Dmytriw2,3, Albert H Chiu4, Brian J Drake1,5, Niki V Alizadeh6, Aditya Bharatha2,3,5, Abhaya V Kulkarni6, Thomas R Marotta2,3,5.   

Abstract

OBJECTIVE: Numerous studies have suggested a relationship between delayed occlusion of intracranial aneurysms treated with the Pipeline Embolization Device (PED) and the presence of an incorporated branch. However, in some cases, flow diversion may still be the preferred treatment option. This study sought to determine whether geometric factors pertaining to relative size and angulation of branch vessel(s) can be measured in a reliable fashion and whether they are related to occlusion rates.
METHODS: Eighty aneurysms treated at a single neurovascular center from November 2008 to June 2014 were identified. Two blinded raters prospectively reviewed the imaging performed at the time of the procedure and measured the following geometric variables: inflow jet/incorporated branch direction angle and branch artery/ parent artery ratio. Delayed occlusion was defined as the absence of complete aneurysmal occlusion at one year. Analysis was performed using logistic regression and intra-class correlation co-efficient (ICC).
RESULTS: Twenty-four (30%) aneurysms with 28 incorporated branches were identified. A trend toward higher inflow jet/incorporated branch direction angle was found in the group of aneurysms demonstrating delayed occlusion when compared to the group with complete occlusion. ICC revealed high correlation. Overall lower one-year occlusion rates of 53% versus 73% for aneurysms with and without incorporated branches, respectively, were also noted.
CONCLUSIONS: The presence of an incorporated branch conferred a 20% absolute risk increase for delayed aneurysmal occlusion. Incorporated branches with a larger angle between the inflow jet and the incorporated branch direction exhibited a trend toward lower occlusion rates. This might be further investigated using a multicenter approach in conjunction with other potentially relevant clinical and angiographic variables.

Entities:  

Keywords:  Interventional neuroradiology; Pipeline Embolization Device; flow diversion; intracranial aneurysm; neurosurgery

Mesh:

Substances:

Year:  2018        PMID: 29871561      PMCID: PMC6259341          DOI: 10.1177/1591019918779229

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  24 in total

1.  Long-Term Follow-Up Results following Elective Treatment of Unruptured Intracranial Aneurysms with the Pipeline Embolization Device.

Authors:  A H Y Chiu; A K Cheung; J D Wenderoth; L De Villiers; H Rice; C C Phatouros; T P Singh; T J Phillips; W McAuliffe
Journal:  AJNR Am J Neuroradiol       Date:  2015-05-21       Impact factor: 3.825

2.  Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results.

Authors:  I Saatci; K Yavuz; C Ozer; S Geyik; H S Cekirge
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-19       Impact factor: 3.825

3.  Endovascular treatment of ophthalmic artery aneurysms: ophthalmic artery patency following flow diversion versus coil embolization.

Authors:  Christopher R Durst; Robert M Starke; David Clopton; H Robert Hixson; Paul J Schmitt; Jean M Gingras; Dale Ding; Kenneth C Liu; R Webster Crowley; Mary E Jensen; Avery J Evans; John Gaughen
Journal:  J Neurointerv Surg       Date:  2015-09-09       Impact factor: 5.836

4.  An outcomes-based grading scale for the evaluation of cerebral aneurysms treated with flow diversion.

Authors:  Min S Park; Marcus D Mazur; Karam Moon; Michael J Nanaszko; John R W Kestle; Lubdha M Shah; Blair Winegar; Felipe C Albuquerque; Philipp Taussky; Cameron G McDougall
Journal:  J Neurointerv Surg       Date:  2016-10-19       Impact factor: 5.836

5.  The pipeline embolization device for the intracranial treatment of aneurysms trial.

Authors:  P K Nelson; P Lylyk; I Szikora; S G Wetzel; I Wanke; D Fiorella
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-09       Impact factor: 3.825

6.  Immediate and midterm results following treatment of unruptured intracranial aneurysms with the pipeline embolization device.

Authors:  W McAuliffe; V Wycoco; H Rice; C Phatouros; T J Singh; J Wenderoth
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-06       Impact factor: 3.825

7.  Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device.

Authors:  I Szikora; Z Berentei; Z Kulcsar; M Marosfoi; Z S Vajda; W Lee; A Berez; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-11       Impact factor: 3.825

8.  Implantation of pipeline flow-diverting stents reduces aneurysm inflow without relevantly affecting static intra-aneurysmal pressure.

Authors:  Hans U Kerl; Hanne Boll; Teresa Fiebig; Giovanna Figueiredo; Alex Förster; Ingo S Nölte; Andrea Nonn; Christoph Groden; Marc A Brockmann
Journal:  Neurosurgery       Date:  2014-03       Impact factor: 4.654

9.  Virtual-versus-Real Implantation of Flow Diverters: Clinical Potential and Influence of Vascular Geometry.

Authors:  P Bouillot; O Brina; H Yilmaz; M Farhat; G Erceg; K-O Lovblad; M I Vargas; Z Kulcsar; V M Pereira
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

10.  Morphologic and Clinical Outcome of Intracranial Aneurysms after Treatment Using Flow Diverter Devices: Mid-Term Follow-Up.

Authors:  Anna-Katharina Breu; Till-Karsten Hauser; Florian H Ebner; Felix Bischof; Ulrike Ernemann; Achim Seeger
Journal:  Radiol Res Pract       Date:  2016-02-23
View more
  1 in total

1.  The Silk Vista Baby - The UK experience.

Authors:  P Bhogal; Hld Makalanda; K Wong; P Keston; J Downer; J C Du Plessis; A Nania; D Simonato; M Fuschi; W Chong; S O'Reilly; I Rennie
Journal:  Interv Neuroradiol       Date:  2021-06-02       Impact factor: 1.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.